Patients’ preferences within randomised trials: systematic review and patient level meta-analysisBMJ 2008; 337 doi: https://doi.org/10.1136/bmj.a1864 (Published 31 October 2008) Cite this as: BMJ 2008;337:a1864
- Preference Collaborative Review Group
- Correspondence to: H Tilbrook, Research Fellow, York Trials Unit, Department of Health Sciences, University of York, York YO10 5DD
- Accepted 27 August 2008
Objective To systematically review fully randomised patient preference trials and to explore the impact of preferences on attrition and outcome by meta-analysis of patient level data.
Data sources Citation search using Science Citation Index and Google Scholar and search of the main electronic databases (Medline, CINAHL, Embase, and AMED) with a combination of key words.
Study selection Fully randomised patient preference trials that compared treatments for any clinical condition were included. Other types of preference trials and crossover trials were excluded. Other inclusion criteria: participants aged 16 years and over; primary, self-reported outcomes measured on a continuous numerical scale. From 167 studies identified and screened, 17 were identified as fully randomised patient preference trials.
Data synthesis Of the 17 trials identified, 11 authors provided raw data for the meta-analysis. Data collected were baseline and follow-up data for the main outcome, randomised allocation data, preference data, and demographic data. Baseline and first post-intervention follow-up data for the main outcome were standardised. To improve homogeneity, data for only the eight musculoskeletal trials (n=1594) were combined. To estimate the effects of preferences on outcomes and attrition, three groups were compared: patients who had a preference and were randomly allocated to their preferred treatment; patients who had a preference and were randomly allocated to the treatment they did not prefer; and patients who had no preference.
Results Patients who were randomised to their preferred treatment had a standardised effect size greater than that of those who were indifferent to the treatment assignment (effect size 0.162, 95% confidence interval 0.011 to 0.314; P=0.04). Participants who received their preferred treatment also did better than participants who did not receive their preferred treatment (effect size 0.152, −0.035 to 0.339), although this was not statistically significant (P=0.11). Participants allocated to their undesired treatment had outcomes that were no different from those who were indifferent. Participants who were allocated to their undesired treatment were less likely to be lost to first follow-up compared with indifferent participants (odds ratio 1.70, 1.076 to 2.693; P=0.02). No difference was found in attrition between patients allocated to their preference and those who were indifferent.
Conclusions Preferences among patients in musculoskeletal trials are associated with treatment effects. In open randomised trials, preferences should be ascertained before randomisation.
This paper was a joint collaboration with the members of the Preference Collaborative Group: Simon J Adamson, J Martin Bland, Elaine M Hay, Ruth E Johnson, Gareth T Jones, Henry Kitchener, Jennifer A Klaber Moffett, Gary J Macfarlane, Hugh MacPherson, Sionnadh McLean, Linsey Nelson, Chris Salisbury, Elaine Thomas, Helen E Tilbrook, and David J Torgerson.
Contributors: JMB provided advice on the statistical analysis and conceived the framework of the statistical analysis. HET did the systematic review as part of her MSc dissertation, did the analysis, and wrote the first draft of the paper. DJT had the idea for the review, supervised HET, identified some papers for inclusion in the review, and helped to write the first draft of the paper. SJA, EMH, REJ, GTJ, HK, JAKM, GJM, HMacP, SMcL, LN, CS, and ET contributed data to the study. SJA, JMB, EMH, GTJ, JAKM, GJM, HMacP, LN, CS, ET, and DJT critically reviewed versions of the manuscript. HET is the guarantor.
Competing interests: None declared.
Provenance and peer review: Not commissioned; externally peer reviewed.
This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.